Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib for First-line Acquired TTP
NCT05135442Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib in thrombotic thrombocytopenic purpura (TTP), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
bortezomib
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT05135442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05135442.